Home
Conditions
Neoplasms

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 114 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease

NCT04039100

Conditions: Blood Protein Disorders, Bone Marrow Transplantation, Cardiovascular Diseases, +17 more
Locations: Rigshospitalet Copenhagen, Østerbro, Denmark

View Trial Details

Completed

Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors

NCT02723864

Conditions: Neoplasms
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

NCT02909452

Conditions: Breast Diseases, Bronchial Diseases, Bronchial Neoplasms, +28 more
Locations: The START Center for Cancer Care San Antonio, Texas, United States

View Trial Details

Completed

Sexual & Gender Minority Competency in Oncology

NCT04198090

Conditions: Neoplasms
Locations: University of Rochester Rochester, New York, United States

View Trial Details

Completed

Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors

NCT01362374

Conditions: Neoplasms
Locations: California Pacific Med Center San Francisco, California, United States

Florida Cancer Specialists - Sarasota Sarasota, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

University Of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

First-in-human Study to Investigate Safety, Blood Levels and Activity of MP0274 in Cancer Patients With HER2-positive Solid Tumors

NCT03084926

Conditions: Neoplasms
Locations: Study Site Frankfurt Frankfurt, Germany

Study Site Heidelberg Heidelberg, Germany

Study Site St. Gallen Sankt Gallen, Canton of St. Gallen, Switzerland

Study Site Cambridge Cambridge, United Kingdom

View Trial Details

Completed

Promoting Cancer Symptom Management in Older Adults

NCT03143829

Conditions: Chemotherapy-induced Nausea and Vomiting, Neoplasms, Pathological Conditions, Signs and Symptoms, +3 more
Locations: Orlando Health Orlando, Florida, United States

View Trial Details

Completed

Latest Imaging SPECT System Evaluation Phase 1

NCT04704349

Conditions: Basal Ganglia Diseases, Brain Diseases, Cardiovascular Diseases, +29 more
Locations: CHR d'Orleans Orléans, France

View Trial Details

Completed

Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT02588612

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: GSK Investigational Site Miami, Florida, United States

GSK Investigational Site Tampa, Florida, United States

GSK Investigational Site Houston, Texas, United States

View Trial Details

Completed

Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors

NCT02859857

Conditions: Astrocytoma, Ependymoma, Glioblastoma, +8 more
Locations: University of Kentucky Markey Cancer Center Lexington, Kentucky, United States

University of New Mexico Cancer Center Albuquerque, New Mexico, United States

University of Cincinnati Barrett Center Cincinnati, Ohio, United States

The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Neoplasms

Neoplasms trial results

Related conditions